SCHEMBL5322284

SCHEMBL5322284

CCCCC(CC)C(=O)NCCc1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.59
KMT2A Q03164 4/20 0.56
MEN1 O00255 3/20 0.56
ALDH1A1 P00352 2/20 0.56
MAPT P10636 1/20 0.56
MAPK1 P28482 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
TSHR P16473 1/20 0.54
LMNA P02545 1/20 0.54
KDM4A O75164 1/20 0.53
NPC1 O15118 2/20 0.53
RAB9A P51151 2/20 0.53
CTSK P43235 1/20 0.53
CYP2C9 P11712 2/20 0.52
CYP2C19 P33261 2/20 0.52
CYP2D6 P10635 1/20 0.52
CA1 P00915 2/20 0.52
CA2 P00918 2/20 0.52
CA7 P43166 1/20 0.52
CA14 Q9ULX7 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19197510 0.85 TSHR (0.64) POLBKMT2AMEN1ALDH1A1MAPT
SCHEMBL15855872 0.83 EPHX2 (0.52) POLBKMT2AMEN1ALDH1A1LMNA
SCHEMBL15855873 0.83 EPHX2 (0.52) POLBKMT2AMEN1ALDH1A1LMNA
SCHEMBL30084805 0.83 CYP2C9 (0.53) POLBKMT2ATSHRKDM4ACTSK
SCHEMBL8615413 0.83 DPP7 (0.60) POLBKMT2AKDM4ACTSKCYP2C9
Hydrochloric Acid SCHEMBL8615285 0.82 DPP7 (0.59) POLBKMT2AMEN1NPC1RAB9A
SCHEMBL10290340 0.80 EPHX2 (0.58) KMT2AMEN1ALDH1A1MAPTMAPK1
SCHEMBL16289859 0.80 EPHX2 (0.58) KMT2AMEN1ALDH1A1MAPTMAPK1
SCHEMBL3795974 0.79 MMP3 (0.58) POLBKMT2AMEN1TSHRKDM4A
SCHEMBL3803203 0.79 MMP3 (0.58) POLBKMT2AMEN1TSHRKDM4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007001335-A2 RAMOPLANIN DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY VICURON PHARMACEUTICALS INC. (US) 2007-01-04 WO claimed
US-20060211603-A1 Ramoplanin derivatives possessing antibacterial activity VICURON PHARMACEUTICALS INC. (US) 2006-09-21 US claimed
WO-2007001335-A2 RAMOPLANIN DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY VICURON PHARMACEUTICALS INC. (US) 2007-01-04 WO disclosed
US-20060211603-A1 Ramoplanin derivatives possessing antibacterial activity VICURON PHARMACEUTICALS INC. (US) 2006-09-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060211603-A1 Ramoplanin derivatives possessing antibacterial activity CLSPN, LMAN2, RPN2 POLB 3888/4885KMT2A 4422/4885MEN1 2853/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.